Close Menu

NEW YORK (GenomeWeb News) — The European Commission will spend €3 million ($3.8 million) to fund AIDS research studies that will use or develop genomics and proteomics technologies, among others, aimed at developing new HIV/AIDS treatments.

The project, which is funded under the Seventh Framework program, will support studies to develop assays and drug screening technologies, as well as research on early drug candidates with acceptable toxicity profiles.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.